Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
1999 | 1 |
2001 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas.
Acta Oncol. 1999;38(5):613-7. doi: 10.1080/028418699431203.
Acta Oncol. 1999.
PMID: 10427950
Clinical Trial.
Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis.
Qu ZX, Pliskin N, Jensen MW, White D, Arnason BG.
Qu ZX, et al.
Arch Neurol. 2001 Jan;58(1):87-90. doi: 10.1001/archneur.58.1.87.
Arch Neurol. 2001.
PMID: 11176940
Clinical Trial.
Item in Clipboard
Biological modifiers (etretinate (changed from etetrinate) and alfa 2a) in the treatment of refractory cutaneous T-cell lymphoma.
Avilés A, Guzmán R, García EL, Díaz-Maqueo JC.
Avilés A, et al.
Cancer Biother Radiopharm. 1996 Feb;11(1):21-4. doi: 10.1089/cbr.1996.11.21.
Cancer Biother Radiopharm. 1996.
PMID: 10851517
Clinical Trial.
Item in Clipboard
Cite
Cite